NAGJI BANSI 4
4 · GoodRx Holdings, Inc. · Filed Oct 21, 2021
Insider Transaction Report
Form 4
Nagji Bansi
President, Healthcare
Transactions
- Sale
Class A Common Stock
2021-10-20$45.00/sh−16,300$733,500→ 0 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-10-19−16,300→ 289,584 totalExercise: $6.84Exp: 2030-06-15→ Class A Common Stock (16,300 underlying) - Sale
Class A Common Stock
2021-10-19$45.02/sh−100$4,502→ 0 total - Exercise/Conversion
Class A Common Stock
2021-10-19$6.84/sh+100$684→ 100 total - Exercise/Conversion
Class A Common Stock
2021-10-20$6.84/sh+16,300$111,492→ 16,300 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-10-19−100→ 305,884 totalExercise: $6.84Exp: 2030-06-15→ Class A Common Stock (100 underlying)
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
- [F2]The option vested and became exercisable as to 25,000 shares on the closing date of the Issuer's initial public offering of securities, and vested or will vest as to 1/48th of the original 400,000 shares monthly thereafter until fully vested on June 10, 2024.